{"id":17864,"date":"2014-04-08T09:30:00","date_gmt":"2014-04-08T07:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/sun-pharma-acquista-rivale-ranbaxy-e-crea-numero-uno-indiano-in-farmaceutica\/"},"modified":"2014-04-08T09:30:00","modified_gmt":"2014-04-08T07:30:00","slug":"sun-pharma-acquista-rivale-ranbaxy-e-crea-numero-uno-indiano-in-farmaceutica","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/sun-pharma-acquista-rivale-ranbaxy-e-crea-numero-uno-indiano-in-farmaceutica\/","title":{"rendered":"Sun Pharma: buys rival Ranbaxy and creates Indian number one in pharmaceuticals"},"content":{"rendered":"

     \"\"<\/span><\/p>\n

(Il Sole 24 Ore Radiocor) \u2013 Rome, April 07 \u2013 The Indian group Sun Pharmaceutical Industries has announced the acquisition of the shares of the struggling rival group Ranbaxy becoming the Indian number one and the world number five in the generic drugs sector. Sun Pharma, explains a note, will pay everything in shares and Ranbaxy shareholders will receive 0.8 Sun Pharma shares for every Ranbaxy share.
Daiichi Sankyo, the Japanese group majority shareholder of Ranbaxy since 2008, will become a "significant" shareholder in the new entity, with a 9 percent stake.
On a like-for-like basis, the new group will have revenues of $4.2 billion for an ebitda of $1.2 billion in 2013. It is present in 65 countries and will feature 47 plants on five continents.<\/span><\/p>\n

<\/p>\n

<\/span><\/p>\n

Related news: http:\/\/www.fedaiisf.it\/Start\/HDefault.aspx?Newsid=8850<\/a> <\/span><\/span><\/p>\n

<\/p>\n

\"\"<\/div>\n

<\/span><\/span><\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

       (Il Sole 24 Ore Radiocor) – Roma, 07 apr – Il gruppo indiano Sun Pharmaceutical Industries ha annunciato l’acquisizione delle azioni del gruppo rivale in difficolta’ Ranbaxy diventando il numero uno indiano e il numero cinque del mondo nel settore dei farmaci generici. Sun Pharma, spiega una nota, paghera’ tutto in azioni e gli …<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-17864","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/17864","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=17864"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/17864\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=17864"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=17864"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=17864"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}